ProMIS Neurosciences (PMN) vs Rafael (RFL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Rafael (RFL) has outperformed ProMIS Neurosciences (PMN) over the past year, gaining 13.0% versus a loss of 32.4%. Over five years, RFL leads with a -95.1% price change compared with -95.9% for PMN. ProMIS Neurosciences is the larger company by market cap ($81.8 million vs $77.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PMN | RFL |
|---|---|---|
| Share price | $9.12 | $1.48 |
| Market cap | $81.79M | $76.96M |
| 1-day change | -0.98% | -0.67% |
| YTD return | +33.53% | +25.42% |
| 1-year return | -32.44% | +12.98% |
| 5-year return | -95.95% | -95.09% |
| EPS (TTM) | $-11.65 | $-0.72 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $27.40 | $3.96 |
| 52-week low | $6.27 | $1.12 |
| Distance from 52-week high | -66.72% | -62.63% |
| Average volume | 84.01K | 159.82K |
| Shares outstanding | 8.97M | 51.21M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RFL has outperformed PMN by 45.4 percentage points over the past year.
PMN vs RFL FAQ
Which is bigger, ProMIS Neurosciences or Rafael?
ProMIS Neurosciences (PMN) is larger, with a market capitalization of $81.79M compared with $76.96M for Rafael (RFL).
Which stock has performed better over the past year, PMN or RFL?
RFL returned +12.98% over the past 12 months, compared with -32.44% for PMN (price return, excluding dividends). Past performance does not predict future results.
Are ProMIS Neurosciences and Rafael in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.